Logo image of BLX.CA

BORALEX INC -A (BLX.CA) Stock Fundamental Analysis

Canada - TSX:BLX - CA09950M3003 - Common Stock

27.75 CAD
-0.01 (-0.04%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

5

Overall BLX gets a fundamental rating of 5 out of 10. We evaluated BLX against 34 industry peers in the Independent Power and Renewable Electricity Producers industry. While BLX is still in line with the averages on profitability rating, there are concerns on its financial health. BLX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BLX was profitable.
BLX had a positive operating cash flow in the past year.
In the past 5 years BLX has always been profitable.
BLX had a positive operating cash flow in each of the past 5 years.
BLX.CA Yearly Net Income VS EBIT VS OCF VS FCFBLX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

BLX has a Return On Assets of -0.13%. This is in the better half of the industry: BLX outperforms 73.53% of its industry peers.
BLX has a Return On Equity of -0.64%. This is in the better half of the industry: BLX outperforms 73.53% of its industry peers.
BLX's Return On Invested Capital of 1.98% is in line compared to the rest of the industry. BLX outperforms 41.18% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BLX is in line with the industry average of 4.55%.
Industry RankSector Rank
ROA -0.13%
ROE -0.64%
ROIC 1.98%
ROA(3y)0.71%
ROA(5y)0.69%
ROE(3y)2.94%
ROE(5y)3.22%
ROIC(3y)2.63%
ROIC(5y)2.59%
BLX.CA Yearly ROA, ROE, ROICBLX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4

1.3 Margins

In the last couple of years the Profit Margin of BLX has grown nicely.
BLX has a better Operating Margin (23.25%) than 67.65% of its industry peers.
BLX's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 75.66%, BLX is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
BLX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.25%
PM (TTM) N/A
GM 75.66%
OM growth 3Y0.2%
OM growth 5Y1.4%
PM growth 3Y19.71%
PM growth 5YN/A
GM growth 3Y-0.46%
GM growth 5Y-0.28%
BLX.CA Yearly Profit, Operating, Gross MarginsBLX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

BLX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BLX has about the same amount of shares outstanding.
BLX has more shares outstanding than it did 5 years ago.
BLX has a worse debt/assets ratio than last year.
BLX.CA Yearly Shares OutstandingBLX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLX.CA Yearly Total Debt VS Total AssetsBLX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

BLX has an Altman-Z score of 0.51. This is a bad value and indicates that BLX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BLX (0.51) is better than 73.53% of its industry peers.
A Debt/Equity ratio of 2.65 is on the high side and indicates that BLX has dependencies on debt financing.
BLX has a Debt to Equity ratio (2.65) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACC0.41
WACC4.79%
BLX.CA Yearly LT Debt VS Equity VS FCFBLX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

BLX has a Current Ratio of 1.08. This is a normal value and indicates that BLX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.08, BLX is in the better half of the industry, outperforming 79.41% of the companies in the same industry.
A Quick Ratio of 1.08 indicates that BLX should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.08, BLX belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
BLX.CA Yearly Current Assets VS Current LiabilitesBLX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

The earnings per share for BLX have decreased strongly by -75.00% in the last year.
Measured over the past years, BLX shows a very strong growth in Earnings Per Share. The EPS has been growing by 58.74% on average per year.
The Revenue for BLX has decreased by -13.45% in the past year. This is quite bad
Measured over the past years, BLX shows a quite strong growth in Revenue. The Revenue has been growing by 8.24% on average per year.
EPS 1Y (TTM)-75%
EPS 3Y58.74%
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-13.45%
Revenue growth 3Y7.27%
Revenue growth 5Y8.24%
Sales Q2Q%2.78%

3.2 Future

Based on estimates for the next years, BLX will show a very strong growth in Earnings Per Share. The EPS will grow by 24.20% on average per year.
Based on estimates for the next years, BLX will show a quite strong growth in Revenue. The Revenue will grow by 15.56% on average per year.
EPS Next Y11.4%
EPS Next 2Y36.53%
EPS Next 3Y30.39%
EPS Next 5Y24.2%
Revenue Next Year6.01%
Revenue Next 2Y9.5%
Revenue Next 3Y7.26%
Revenue Next 5Y15.56%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BLX.CA Yearly Revenue VS EstimatesBLX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
BLX.CA Yearly EPS VS EstimatesBLX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 115.63, the valuation of BLX can be described as expensive.
70.59% of the companies in the same industry are more expensive than BLX, based on the Price/Earnings ratio.
BLX is valuated expensively when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 21.89 indicates a rather expensive valuation of BLX.
Based on the Price/Forward Earnings ratio, BLX is valued a bit cheaper than the industry average as 73.53% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.57, BLX is valued at the same level.
Industry RankSector Rank
PE 115.63
Fwd PE 21.89
BLX.CA Price Earnings VS Forward Price EarningsBLX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

64.71% of the companies in the same industry are cheaper than BLX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.2
BLX.CA Per share dataBLX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BLX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BLX's earnings are expected to grow with 30.39% in the coming years.
PEG (NY)10.15
PEG (5Y)N/A
EPS Next 2Y36.53%
EPS Next 3Y30.39%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.38%, BLX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.48, BLX is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.43, BLX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.38%

5.2 History

The dividend of BLX has a limited annual growth rate of 0.48%.
BLX has been paying a dividend for at least 10 years, so it has a reliable track record.
BLX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years10
BLX.CA Yearly Dividends per shareBLX.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

BLX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
BLX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-680%
EPS Next 2Y36.53%
EPS Next 3Y30.39%
BLX.CA Yearly Income VS Free CF VS DividendBLX.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

BORALEX INC -A

TSX:BLX (10/10/2025, 7:00:00 PM)

27.75

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-07 2025-11-07
Inst Owners61.04%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap2.85B
Analysts76.92
Price Target39.53 (42.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.38%
Yearly Dividend0.66
Dividend Growth(5Y)0.48%
DP-680%
Div Incr Years0
Div Non Decr Years10
Ex-Date08-29 2025-08-29 (0.165)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-125.9%
Min EPS beat(2)-210.01%
Max EPS beat(2)-41.8%
EPS beat(4)0
Avg EPS beat(4)-81.81%
Min EPS beat(4)-210.01%
Max EPS beat(4)-19.18%
EPS beat(8)3
Avg EPS beat(8)-27.38%
EPS beat(12)4
Avg EPS beat(12)-32.93%
EPS beat(16)7
Avg EPS beat(16)-21.99%
Revenue beat(2)0
Avg Revenue beat(2)-15.34%
Min Revenue beat(2)-16.5%
Max Revenue beat(2)-14.18%
Revenue beat(4)0
Avg Revenue beat(4)-12.56%
Min Revenue beat(4)-16.5%
Max Revenue beat(4)-5.31%
Revenue beat(8)2
Avg Revenue beat(8)-4.72%
Revenue beat(12)5
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)-1.5%
PT rev (1m)0%
PT rev (3m)-0.51%
EPS NQ rev (1m)-53.25%
EPS NQ rev (3m)-20.51%
EPS NY rev (1m)-10.18%
EPS NY rev (3m)-16.51%
Revenue NQ rev (1m)-0.84%
Revenue NQ rev (3m)-5.64%
Revenue NY rev (1m)-2.68%
Revenue NY rev (3m)-2.83%
Valuation
Industry RankSector Rank
PE 115.63
Fwd PE 21.89
P/S 3.44
P/FCF N/A
P/OCF 22.63
P/B 1.81
P/tB 7.69
EV/EBITDA 14.2
EPS(TTM)0.24
EY0.86%
EPS(NY)1.27
Fwd EY4.57%
FCF(TTM)-5.63
FCFYN/A
OCF(TTM)1.23
OCFY4.42%
SpS8.08
BVpS15.31
TBVpS3.61
PEG (NY)10.15
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.13%
ROE -0.64%
ROCE 2.79%
ROIC 1.98%
ROICexc 2.08%
ROICexgc 2.55%
OM 23.25%
PM (TTM) N/A
GM 75.66%
FCFM N/A
ROA(3y)0.71%
ROA(5y)0.69%
ROE(3y)2.94%
ROE(5y)3.22%
ROIC(3y)2.63%
ROIC(5y)2.59%
ROICexc(3y)2.85%
ROICexc(5y)2.78%
ROICexgc(3y)3.67%
ROICexgc(5y)3.66%
ROCE(3y)3.71%
ROCE(5y)3.65%
ROICexcg growth 3Y-1.44%
ROICexcg growth 5Y1.01%
ROICexc growth 3Y1.57%
ROICexc growth 5Y1.49%
OM growth 3Y0.2%
OM growth 5Y1.4%
PM growth 3Y19.71%
PM growth 5YN/A
GM growth 3Y-0.46%
GM growth 5Y-0.28%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF N/A
Debt/EBITDA 8.41
Cap/Depr 232.67%
Cap/Sales 84.94%
Interest Coverage 1.33
Cash Conversion 25.4%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 0.51
F-Score4
WACC4.79%
ROIC/WACC0.41
Cap/Depr(3y)110.38%
Cap/Depr(5y)89.71%
Cap/Sales(3y)36.6%
Cap/Sales(5y)31.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75%
EPS 3Y58.74%
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y11.4%
EPS Next 2Y36.53%
EPS Next 3Y30.39%
EPS Next 5Y24.2%
Revenue 1Y (TTM)-13.45%
Revenue growth 3Y7.27%
Revenue growth 5Y8.24%
Sales Q2Q%2.78%
Revenue Next Year6.01%
Revenue Next 2Y9.5%
Revenue Next 3Y7.26%
Revenue Next 5Y15.56%
EBIT growth 1Y-28.78%
EBIT growth 3Y7.49%
EBIT growth 5Y9.76%
EBIT Next Year140.93%
EBIT Next 3Y40.07%
EBIT Next 5Y26.65%
FCF growth 1Y-235.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.11%
OCF growth 3Y-14.58%
OCF growth 5Y-6.07%